ROCKVILLE, Md., March24, 2022(GLOBE NEWSWIRE) -- As per latest revised industry analysis by Fact.MR, a market research and competitive intelligence provider, the global closed blood sampling systems market was valued at US$ 72.6 Mn in 2021, and is expected to exhibit a CAGR of 5.9% over the forecast period (2022-2032). Closed blood sampling systems find key applications in treatment procedures for cancer patients calling for infusions in hospital settings and other healthcare facilities. This delivers an opportunity for manufactures to surge their product sales.
The global closed blood sampling systems market is projected to witness substantial growth over the forecast period owing to rising demand for safe blood collection procedures for prevention of contamination and infections associated with the environment within healthcare settings. Emerging markets, especially large markets such as India and China, have a significantly large and untapped potential for market expansion.
Rising adoption of advanced closed systems for blood sampling through variable needle-free access options have been featured in several product offerings by manufacturers. Growing awareness regarding the importance of safe blood transfusion for extending the quality of health as well as outlook of patient life promotes demand for safe blood collection techniques, thus boosting the sales of closed blood monitoring systems.
Get an Idea about the Offerings Of Our Closed Blood Sampling Systems Market
Report from this Brochure at
|Closed Blood Sampling Systems Market Size (2021A)||US$ 72.64 Mn|
|Estimated Market Value (2022E)||US$ 76.32 Mn|
|Forecasted Market Value (2032F)||US$ 135.83 Mn|
|Global Market Growth Rate (2022-2032)||5.9% CAGR|
|East Asia Market Share (2021)||~ 14.5%|
|East Asia Growth Rate (2022-2032)||6.9% CAGR|
|China Growth Rate (2022-2032)||7.6% CAGR|
|Market Share of Top 3 Countries||~47.5%|
|Key Companies Profiled||• ICU Medical, Inc.• Smiths Medical, Inc.• Edwards Lifesciences Corporation• Merit Medical Systems• Utah Medical Products, Inc.• Elcam Medical• CardioMed Supplies Inc.• Shenzhen Antmed Co., Ltd.|
As per Fact.MR’s projections, single-line blood sampling systems held a substantial market share of 25.5% in 2021. Closed blood sampling systems accounted for around 0.3% share of the global blood screening market in 2021.
Sales Analysis of Closed Blood Sampling Systems from 2017 to 2021 Vs Market Outlook for 2022 to 2032
Demand for closed blood sampling systems depends upon the global factors associated with rising measures by healthcare facilities towards comprehensive surgical care. Surgical care is a prime and essential practice to effectively manage a varied range of health conditions.
Sales revenue from closed blood sampling systems are expected to increase at a considerable growth rate over the next ten years at a CAGR of 5.9%.
Increasing cases of injury and wound, malignancy, chronic diseases such as cardiovascular diseases and diabetes, obstructed labor, and infections, globally, have accelerated demand for safe and efficient blood sampling techniques, thus posing a positive impact on the growth of the closed blood sampling devices market.
The global closed blood sampling systems market expanded at 4.8% CAGR over the past 5 years.
To learn more about Closed Blood Sampling Systems Market, you can get in touch with our Analyst at
Key Takeaways from Market Study
“High prevalence of needle stick injuries and risk of infections associated with them are set to promote the sales of closed blood sampling systems,” says an analyst of Fact.MR.
Key market players such as ICU Medical Inc. and Elcam Medical are focusing on development with indication-centric applications for safe blood collection techniques.
Additionally, manufacturers follow acquisition activities in order to build a comprehensive product portfolio and gain operational capacities for production at lower costs.
Get Customization on this Closed Blood Sampling Market Report for Specific Research Solutions at
Key Segments Covered in Closed Blood Sampling Systems Industry Research
To understand how our report can bring difference to your business strategy, Purchase a copy of this report at https://www.factmr.com/checkout/4002
What Does the Report Cover?
Fact.MR offers a unique perspective and actionable insights on the closed blood sampling systems market in its latest study, presenting historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.
The research study is based on the sampling system (single-line blood sampling systems, double-line blood sampling systems, triple-line blood sampling systems, and pressure transducer/ monitoring kits and accessories), modality (arm-mounted sampling systems and pole-mounted sampling systems), age group (neonatal/paediatric and adults), and end user (hospitals, specialty clinics, ambulatory surgical centres, cancer research institutes, blood banks, and others), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).
Check out more studies related to Healthcare Industry, conducted by Fact.MR:
U.S. Antiretroviral (ARV) Agents Market Outlook - U.S. is considered to be the most influencing regions in the global antiretroviral (ARV) agents market due to the existence of prime biopharmaceutical manufacturing companies.
High Adoption of Fast Melt Tablets Expected To Boost the Demand - High adoption of fast-melt tablet by geriatric population give demand progress for fast melt tablets market during the forecast period. First pass metabolism is big issue in a conventional oral formulation that can be prevented with the help of fast melt tablet.
Sales Analysis of Psychedelic Drugs from 2016 to 2020 Vs Market Outlook for 2021 to 2031 - Rising awareness regarding mental health disorders and illness has resulted in higher adoption of treatment measures pertaining to psychological ailments by the general population across the globe.
Impact of COVID on Testosterone Nasal Gels Market - A study conducted by the University of Mersin and the Mersin City Education and Research Hospital in Turkey found that males affected with COVID-19 showed a decrease in testosterone levels.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583